#39 Early cancer detection with Marcel Gehrung, data driven diagnostics, current standard of care, oesophageal cancer, novel testing and current standard of care

Marcel, a scientist and serial entrepreneur, holds a PhD in Machine Learning in Healthcare from the University of Cambridge. He was named on the Forbes 30 under 30 list, won the Alexander Fleming Prize from the Gates Foundation for his contribution to global public health and the Prix Galien Award for the best medical technology with Cyted’s core product called Cytosponge™, a novel test for the early detection of cancer in the oesophagus. On this episode, he discusses the pre-cancerous Barrett esophagus alongside the causes of this condition, the minimally invasive technique his company has developed for the detection of oesophageal cancer together with its comparison to the traditional methods of endoscopy, the process of acquiring funding for his startup, how acid reflux and heartburn could be early warning signs of the disease, his advice for founders and the importance of developing different types of teams at various stages of your business. Get in touch with Marcel Gehrung - https://www.linkedin.com/in/marcel-gehrung/ or https://cyted.ai/ Get in touch with Karandeep Badwal - https://www.linkedin.com/in/karandeepbadwal/ Follow Karandeep on YouTube - https://www.youtube.com/c/QRAMedical Subscribe to the Podcast